StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Restricted Cash and Investments by Quarter

Restricted Cash and Investments ($M)

QuarterlyAnnual

Elevance Health Restricted Cash and Investments: $500M in Q3 2026, up 25.9% from a year earlier.

Latest, Q3 2026
500
Period ended Sep 30, 2026
Change on a year earlier
+25.9%
397 in Q3 2025
History
44 quarters
Since Q4 2015
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:RestrictedCashAndInvestmentsCurrent (2026-09-30): 500,000,000.00”

Source: ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRestricted Cash and Investments ($M)Year on yearSource
Q3 2026Sep 30, 2026500+25.9%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q2 2026Jun 30, 2026668+28.7%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q1 2026Mar 31, 2026527-24.2%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q4 2025Dec 31, 2025348-14.9%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q3 2025Sep 30, 2025397+17.1%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q2 2025Jun 30, 2025519+29.8%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q1 2025Mar 31, 2025695+39.3%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q4 2024Dec 31, 2024409+39.1%ELV 10-K (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q3 2024Sep 30, 2024339+13.0%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q2 2024Jun 30, 2024400+2.3%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q1 2024Mar 31, 2024499-4.0%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q4 2023Dec 31, 2023294+14.0%ELV 10-K (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q3 2023Sep 30, 2023300+3.1%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q2 2023Jun 30, 2023391+27.8%ELV 10-Q/A (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q1 2023Mar 31, 2023520+221.0%ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Q4 2022Dec 31, 2022258+49.1%ELV 10-K (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗

Cite this data

StockData. (2026). Elevance Health Restricted Cash and Investments ($M), quarterly Q4 2015–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-restricted-cash-and-investments

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.